Auristatin F-d8

CC([C@@H](C(N[C@@]([2H])(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])[2H])C(N(C)[C@H]([C@H](OC)CC(N1CCC[C@]1([C@@H]([C@H](C(N[C@@H](CC2=CC=CC=C2)C(O)=O)=O)C)OC)[H])=O)[C@H](CC)C)=O)=O)N(C)C)C

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Park MH, et, al. Pharmacokinetic and Metabolism Studies of Monomethyl Auristatin F via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry. Molecules. 2019 Jul 29;24 (15) :2754.|[3]Roy S, et al. SMI-Ribosome inactivating protein conjugates selectively inhibit tumor cell growth. Chem Commun (Camb) . 2017 Apr 11;53 (30) :4234-4237.